CN

China

51491 clinical trials

Find Trials

Clinical Trials (51491)

Showing 20 of 51,491 trialsScroll for more
NCT07091630Phase 35 sites

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Recruiting
NCT05979441Phase 39 sites

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Enrolling By Invitation
NCT05556460Not Applicable2 sites

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

Recruiting
NCT07358689Phase 21 site

Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer

Not Yet Recruiting
NCT07225569Phase 24 sites

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting
NCT07201493Not Applicable1 site

Evaluation of New Color Temperature Adjustment Mode in Preventing Dry Eye and Visual Fatigue

Completed
NCT06676631Phase 11 site

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

Recruiting
NCT06772623Phase 114 sites

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Recruiting
NCT07263776Phase 354 sites

Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2

Active Not Recruiting
NCT06047964Not Applicable9 sites

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis

Active Not Recruiting
NCT06456346Phase 324 sites

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Recruiting
NCT0734760023 sites

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

Recruiting
NCT07176390Phase 28 sites

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Active Not Recruiting
NCT05685238Phase 313 sites

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)

Active Not Recruiting
NCT05319730Phase 18 sites

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Recruiting
NCT03462316Phase 11 site

NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma

Completed
NCT06962800Phase 325 sites

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Recruiting
NCT03890068Phase 21 site

Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma

Completed
NCT07138677Not Applicable1 site

Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial

Completed
NCT07133633Phase 29 sites

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Recruiting